Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

Abstract Introduction Due to the high cost and high failure rate of ascertaining amyloid positron emission tomography positivity (PET+) in patients with earlier stage Alzheimer’s disease (AD), an effective pre-screening tool for amyloid PET scans is needed. Methods Patients with mild cognitive impai...

Full description

Bibliographic Details

Main Authors:	Szu-Ying Lin, Kun-Ju Lin, Po-Chen Lin, Chin-Chang Huang, Chiung-Chih Chang, Yi-Chung Lee, Ing-Tsung Hsiao, Tzu-Chen Yen, Wen-Sheng Huang, Bang-Hung Yang, Pei-Ning Wang
Format:	Artigo
Language:	Inglês
Published:	BMC 2019-12-01
Series:	Alzheimer’s Research & Therapy
Subjects:	Amyloid PET APOE Plasma Aβ Biomarkers MCI AD
Online Access:	https://doi.org/10.1186/s13195-019-0566-0
Tags:	Add Tag No Tags, Be the first to tag this record!